Remove 2010 Remove Chemicals Remove Development Remove Marketing
article thumbnail

Building Your Brand “Buddy the Elf” Style – Part 1 :: Women on.

Women on Business

For others, adults, Buddy was a “chemically imbalanced” adult man who thinks and dresses like an elf running around through the streets of New York City. But let’s assume that Buddy is indeed an elf, developed and created by the North Pole to fill a need…to make toys.

Brand 215
article thumbnail

Effective Communication Skills: You Don't Know Until You Ask | Guy.

The Recovering Engineer

He has degrees in Chemical Engineering and he served as a Nuclear Engineering officer in the U.S. Reply Guy Harris says: March 30, 2010 at 11:02 pm Hi Lori, Thanks for stopping by and leaving your comment. Reply Generate Huge Profits With Social Media Marketing says: March 27, 2010 at 9:47 pm [.] Great input!

Skills 200
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Businesses Need to Know About Sustainable Development Goals

Harvard Business Review

First, the global goals campaign represents a significant new opportunity for companies that view emerging and frontier markets as their source of long-term growth. According to estimates from McKinsey, consumers in these markets could be worth $30 trillion by 2025 — a significant step up from the 2010 value of $12 trillion.

Goal 8
article thumbnail

How Organic Wine Finally Caught On

Harvard Business Review

The paltry market for organic wine around the world belies the fact that over the past half century, countless organic winegrowers and vintners have dedicated great effort to creating a larger market for the category, without much success. As organic wine standards were being developed in Europe and the U.S., Early Struggles.

article thumbnail

The Company Outsmarting Big Pharma in Africa

Harvard Business Review

Most of its sales are in the developing world (including 40% in Africa) — where it sells its HIV drugs for about $350 per year per patient — yet it is as profitable as the pharma giants of Europe, North America, and Japan. It has doubled its market cap in the five years and sales reached almost $1.5

Company 11
article thumbnail

How to Know If a Spin-Off Will Succeed

Harvard Business Review

A 2010 meta-analysis detailed many of the different issues that make divestiture so hard to evaluate consistently. The diverging fortunes of two recent spin-offs in the energy industry illustrate how financial markets value autonomy from the parent.

article thumbnail

Kodak’s Downfall Wasn’t About Technology

Harvard Business Review

Today, the term increasingly serves as a corporate bogeyman that warns executives of the need to stand up and respond when disruptive developments encroach on their market. Once one of the most powerful companies in the world, today the company has a market capitalization of less than $1 billion. Why did this happen?